Conference presentation
The GELATI Trial
19th Annual Meeting on Clinical Trials in Intensive Care (ANZICS) 2017 (Noosa, QLD, Australia, 03/2017)
2017
Abstract
Synthetic colloid fluids are frequently used for blood volume expansion in critically ill patients. Starch-based synthetic colloid fluids have been associated with increased risk of acute kidney injury. There is some evidence that gelatine-based colloid fluids may also pose a similar risk. This randomised open-label controlled pilot trial will assess the effects of 4% succinylated gelatine fluid on urinary biomarkers of acute kidney injury in Intensive Care Unit (ICU) patients. This study will also assess clinical outcomes, as secondary endpoints, including change in AKI stage, need for renal replacement therapy (RRT), ICU length of stay and mortality.
Details
- Title
- The GELATI Trial
- Authors/Creators
- K.M. Ho (Author/Creator)L. Smart (Author/Creator)
- Conference
- 19th Annual Meeting on Clinical Trials in Intensive Care (ANZICS) 2017 (Noosa, QLD, Australia, 03/2017)
- Identifiers
- 991005543262207891
- Murdoch Affiliation
- School of Veterinary and Life Sciences
- Language
- English
- Resource Type
- Conference presentation
Metrics
30 Record Views